DeepIntent
DeepIntent is a healthcare-focused DSP and marketing cloud for pharmaceutical advertising.
Analyst Perspective
DeepIntent is a private US healthcare advertising technology company focused on pharmaceutical marketing. Its core offering is a healthcare-specific demand-side platform used by pharma brands, healthcare marketers, and agencies to plan, activate, optimise, and measure programmatic campaigns across channels including CTV, display, audio, video, and DOOH. The company combines media buying with healthcare audience data, clean room capabilities, and outcome measurement linked to clinical and prescribing signals. The business generates revenue primarily from media spend flowing through its DSP, supplemented by software and data revenue from products such as Helix, Cortex, Outcomes, and workflow tools for audience building and orchestration. Its customers are business buyers rather than consumers, chiefly enterprise pharmaceutical companies, healthcare-focused agencies, media planners, and marketing operations teams that need HIPAA-conscious targeting, healthcare datasets, and campaign measurement aligned to pharmaceutical KPIs such as script lift.
Analyst Signal Briefing
Updated: 2 Jul 2026DeepIntent is capitalising on the pharmaceutical sector's rapid transition to digital advertising, which is currently forecast to reach $26.2 billion. Following its majority-stake acquisition by Vitruvian Partners, the firm appointed former The Trade Desk executive Ian Colley as Chief Marketing Officer and launched Helix AI, an agentic artificial intelligence platform for cross-platform activation and healthcare-specific planning. These strategic initiatives, alongside new premium live-streaming partnerships, focus on addressing complex regulatory and privacy constraints to successfully capture market share from legacy demand-side platforms.
Explorer Tier
Start exploring for free
Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.
- View public Company Profiles
- Save/watch companies
- Build your first Watchlist
- Access additional market signals
Key insights about DeepIntent
Category Differentiation
DeepIntent is a healthcare advertising technology platform for pharmaceutical media buying and measurement, not a general consumer health app or a healthcare provider. It is also distinct from broad horizontal DSPs because its core differentiation is healthcare-specific data, compliance, and outcome measurement.
DeepIntent: About
DeepIntent operates a vertical AdTech platform model centred on healthcare and pharmaceutical advertising. It creates value by combining compliant healthcare data, audience creation, programmatic media buying, marketplace supply access, and measurement into an integrated platform stack. This allows enterprise advertisers and agencies to run campaigns in regulated healthcare contexts with more relevant targeting and more sector-specific attribution than generalist ad platforms typically provide.
How DeepIntent Works & Monetises
Business model analysis and core revenue streams
DeepIntent primarily monetises through a percentage take-rate or platform economics attached to programmatic media spend executed through its DSP. It also appears to generate SaaS-style revenue from access to its healthcare marketing cloud, clean room, analytics, measurement, and workflow tools, plus premium data and audience access. Commercial arrangements likely include enterprise contracts, platform access fees, minimum spend commitments, bundled data-and-media packages, and premium inventory marketplace fees.
Revenue Channels
Side-by-Side Comparisons
Compare DeepIntent directly with top competitors
Products & Services in Categories
Verified structural categorizations from the graph
Technology
Media Channel
DeepIntent: Key Competitors & Alternatives
- Analyze Profile →
Healthcare adtech platform for pharma, publishers and HCP targeting.
- Analyze Profile →
Vertical SaaS, publishing and advertising platforms across specialist markets.
- Analyze Profile →
Verified clinician network monetised through research, insights and healthcare advertising.
Recent Signals (DeepIntent)
Pharma advertisers adopt specialized ad tech
Pharmaceutical marketers are increasingly shifting ad dollars from traditional TV to digital channels and adopting specialized ad tech built for healthcare’s regulatory and privacy constraints. Industry data cited in the article forecasts healthcare and pharma digital ad spending at $26.2 billion versus $6.9 billion for traditional media, with social surpassing linear TV in 2025. Sources tell Digiday that niche vendors such as DeepIntent, Patient Point and Pulsepoint are winning share from legacy DSPs. DeepIntent, after a majority-stake sale to Vitruvian Partners for $637 million in late 2025, unveiled a healthcare-focused agentic AI product called Helix AI and new tools to buy premium live-streaming TV inventory, touting partnerships with major broadcasters and sports-rights holders. Agency and ad buyers say evolving FDA and state-level regulations are driving privacy‑forward targeting and measurement approaches.
Read original sourceFormer Trade Desk CMO Joins DeepIntent
Ian Colley, former chief marketing officer of The Trade Desk, left TTD in April and has joined healthcare-specialist DSP DeepIntent as its CMO. Colley says he chose DeepIntent because healthcare programmatic advertising can drive commercial insights that help bring treatments to market. The article notes The Trade Desk faced a Publicis-commissioned audit and client warnings in March that later led to a joint statement and Publicis re-adding TTD to its approved vendor list. DeepIntent, a US-focused DSP with roughly 400 employees, has launched products including a cloud platform called Helix AI and aims to evolve from a DSP into a planning platform for big pharma using agentic AI.
Read original sourceDeepIntent Launches Helix AI, Bringing Agentic AI and Cross-Platform Activation to Healthcare Marketers
DeepIntent has launched Helix AI, which aims to enhance healthcare marketing through agentic AI and cross-platform activation.
Read original sourceDeepIntent: Frequently Asked Questions
What is DeepIntent?
DeepIntent is a healthcare-focused advertising technology company that provides a DSP, data tools, and measurement products for pharmaceutical marketing.
Who uses DeepIntent?
Its primary users are pharmaceutical brands, healthcare marketers, media agencies, programmatic teams, and pharma marketing operations teams.
How does DeepIntent make money?
It makes money mainly from media spend flowing through its DSP, alongside software, data, and analytics fees for its broader healthcare marketing platform.
Company Facts
- Founded
- 2016
- Headquarters
- 4 Bryant Park, 4th Floor New York, NY 10018
- Core Segment
- AdTech Vendor
- Company Size
- 201–500
- Official Link
- deepintent.com